Nan Fung Group Holdings

Latest statistics and disclosures from Nan Fung Group Holdings's latest quarterly 13F-HR filing:

Tip: Access up to 7 years of quarterly data

Positions held by Nan Fung Group Holdings consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for Nan Fung Group Holdings

Companies in the Nan Fung Group Holdings portfolio as of the March 2022 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Illumina (ILMN) 21.5 $45M 130k 349.40
Harmony Biosciences Hldgs In (HRMY) 17.7 $37M 769k 48.65
Karuna Therapeutics Ord (KRTX) 14.1 $30M 235k 126.79
Eargo (EAR) 7.2 $15M 2.9M 5.29
Somalogic Class A Com (SLGC) 6.5 $14M 1.7M 8.02
Exscientia Ads (EXAI) 5.3 $11M NEW 770k 14.40
Seagen (SGEN) 3.2 $6.8M NEW 47k 144.05
Rani Therapeutics Hldgs Com Cl A (RANI) 3.2 $6.7M 494k 13.50
Xenon Pharmaceuticals (XENE) 2.9 $6.0M 198k 30.57
Vir Biotechnology (VIR) 2.6 $5.4M +31% 211k 25.72
Bolt Biotherapeutics (BOLT) 1.5 $3.2M 1.2M 2.74
Beam Therapeutics (BEAM) 1.5 $3.1M 55k 57.30
Incyte Corporation (INCY) 1.3 $2.7M NEW 34k 79.41
Beigene Sponsored Adr (BGNE) 1.1 $2.3M NEW 12k 188.57

Setup an alert

Nan Fung Group Holdings will file the next quarterly 13-HR in about 3 months. Would you like to be notified?

Otonomy (OTIC) 1.0 $2.0M 851k 2.40
Sierra Oncology Com New (SRRA) 0.8 $1.7M 53k 32.05
Entrada Therapeutics (TRDA) 0.8 $1.6M NEW 174k 9.39
Galera Therapeutics (GRTX) 0.7 $1.5M 613k 2.38
Exelixis (EXEL) 0.7 $1.5M 64k 22.66
Pacific Biosciences of California (PACB) 0.6 $1.3M NEW 145k 9.10
Replimune Group (REPL) 0.6 $1.3M NEW 75k 16.98
Invitae (NVTA) 0.6 $1.2M +7% 156k 7.97
EXACT Sciences Corporation (EXAS) 0.6 $1.2M 18k 69.92
Kalvista Pharmaceuticals (KALV) 0.6 $1.2M 79k 14.74
Chemocentryx (CCXI) 0.4 $898k NEW 36k 25.06
ACADIA Pharmaceuticals (ACAD) 0.3 $726k NEW 30k 24.21
Alx Oncology Hldgs (ALXO) 0.3 $709k 42k 16.90
2seventy Bio Common Stock (TSVT) 0.3 $687k NEW 40k 17.06
Dbv Technologies S A Sponsored Adr (DBVT) 0.3 $590k 371k 1.59
Satsuma Pharmaceuticals Ord (STSA) 0.3 $543k 143k 3.80
Ascendis Pharma A/s Sponsored Adr (ASND) 0.2 $489k NEW 4.2k 117.32
BioMarin Pharmaceutical (BMRN) 0.2 $471k NEW 6.1k 77.02
Affimed Therapeutics B V (AFMD) 0.2 $355k NEW 81k 4.37
Argenx Se Sponsored Adr (ARGX) 0.2 $350k NEW 1.1k 315.32
Rubius Therapeutics (RUBY) 0.1 $313k 57k 5.51
Sarepta Therapeutics (SRPT) 0.1 $306k NEW 3.9k 78.12
Reata Pharmaceuticals Cl A (RETA) 0.1 $271k 8.3k 32.79
Fibrogen (FGEN) 0.1 $177k NEW 15k 12.00
Synlogic (SYBX) 0.1 $165k 69k 2.40
Kodiak Sciences (KOD) 0.1 $151k NEW 20k 7.70
Abcellera Biologics (ABCL) 0.1 $122k NEW 13k 9.74
Day One Biopharmaceuticals I (DAWN) 0.1 $114k NEW 11k 9.96
Dyne Therapeutics (DYN) 0.1 $112k 12k 9.63
Cerus Corporation (CERS) 0.0 $78k NEW 14k 5.50
Tcr2 Therapeutics Inc cs (TCRR) 0.0 $53k NEW 19k 2.74

Past Filings by Nan Fung Group Holdings

SEC 13F filings are viewable for Nan Fung Group Holdings going back to 2021